Literature DB >> 986150

Blood leucocyte enzymes. III. Diurnal rhythm of activity in isolated lymphocytes of normal subjects and chronic lymphatic leukaemia patients.

B Ramot, F Brok-Simoni, E Chweidan, Y E Ashkenazi.   

Abstract

The activities of glucose-6-phosphate dehydrogenase (D-glucose-6-phosphate: NADP oxidoreductase, G6PD), 6 phosphate glucono dehydrogenase (6 phospho-D-gluconate: NADP oxidoreductase, 6PGD) lactate dehydrogenase (D-lactate: NAD oxidoreductase, LDH), glutamate oxaloacetate transaminase (L-aspartate: 2-oxo-glutarate aminotransferase, GOT) and hexokinase (ATP: D-hexo-6-phosphotrans-ferase, Hx) were measured over 24 h in isolated lymphocytes of normal subjects and in white cells of patients with chronic lymphatic leukaemia (CLL). The activitty patterns of all enzymes in the normal lymphocytes were similar. A computed pattern of all the results exhibited a circadian rhythm of activity with the highest level at 16.00 hours. The oscillations in the activities of the same enzymes in the CLL cells differed among the patients, although all the enzymes of the same individual showed a similar diurnal rhythmic pattern. All peaks in this group appeared between 20.00 and 08.00 hours. The possible importance of these observations in setting up therapeutic schedules was raised.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 986150     DOI: 10.1111/j.1365-2141.1976.tb00176.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Long ultradian rhythms in red blood cells and ghost suspensions: possible involvement of cell membrane.

Authors:  L Peleg; A Dotan; P Luzato; I E Ashkenazi
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

2.  Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.

Authors:  F A Lévi; C Canon; Y Touitou; A Reinberg; G Mathé
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 3.  Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Authors:  Kjeld Schmiegelow; Stine N Nielsen; Thomas L Frandsen; Jacob Nersting
Journal:  J Pediatr Hematol Oncol       Date:  2014-10       Impact factor: 1.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.